Published in Heart on May 01, 2012
Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial. Eur Heart J (2011) 1.88
n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study. Circulation (2011) 1.71
Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel. J Am Coll Cardiol (2011) 1.64
Ghrelin restores the endothelin 1/nitric oxide balance in patients with obesity-related metabolic syndrome. Hypertension (2009) 1.62
Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome. Am J Physiol Endocrinol Metab (2010) 1.60
Role of cyclooxygenase products in the regulation of vascular tone and in the endothelial vasodilator function of normal, hypertensive, and hypercholesterolemic humans. Am J Cardiol (2002) 1.46
CD8+ T lymphocytes regulate the arteriogenic response to ischemia by infiltrating the site of collateral vessel development and recruiting CD4+ mononuclear cells through the expression of interleukin-16. Circulation (2005) 1.44
Increased activity of endogenous endothelin in patients with type II diabetes mellitus. Circulation (2002) 1.42
Coexistence of functional angiotensin II type 2 receptors mediating both vasoconstriction and vasodilation in humans. J Hypertens (2011) 1.40
Targeting myocardial substrate metabolism in heart failure: potential for new therapies. Eur J Heart Fail (2012) 1.36
Reduced endothelium-dependent and -independent dilation of conductance arteries in African Americans. J Am Coll Cardiol (2002) 1.36
Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy. J Am Coll Cardiol (2011) 1.34
Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual. J Hypertens (2007) 1.32
Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Intern Emerg Med (2011) 1.30
Methods for evaluating endothelial function in humans. Hypertension (2007) 1.20
Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation (2005) 1.18
Human obesity and endothelium-dependent responsiveness. Br J Pharmacol (2012) 1.14
Oxidative stress in diabetes: implications for vascular and other complications. Int J Mol Sci (2013) 1.13
High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance. Am J Physiol Heart Circ Physiol (2005) 1.11
Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes. Atherosclerosis (2009) 1.08
Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome. J Clin Endocrinol Metab (2011) 1.06
Decreased plasma adiponectin concentration in major depression. Neurosci Lett (2006) 1.04
Vascular, metabolic, and inflammatory abnormalities in normoglycemic offspring of patients with type 2 diabetes mellitus. Metabolism (2007) 1.03
Enhanced vascular activity of endogenous endothelin-1 in obese hypertensive patients. Hypertension (2003) 1.03
Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome. Nutr Metab Cardiovasc Dis (2007) 1.01
Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients. Circulation (2005) 1.00
Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy. J Clin Psychiatry (2006) 0.99
Ghrelin has novel vascular actions that mimic PI 3-kinase-dependent actions of insulin to stimulate production of NO from endothelial cells. Am J Physiol Endocrinol Metab (2006) 0.99
Effects of GLP-1 on forearm vasodilator function and glucose disposal during hyperinsulinemia in the metabolic syndrome. Diabetes Care (2012) 0.99
Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines. Cardiol Res Pract (2011) 0.96
Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension. Circulation (2002) 0.95
Ethnic differences in the vasoconstrictor activity of endogenous endothelin-1 in hypertensive patients. Circulation (2004) 0.95
Aortic stiffness and hypotension episodes are associated with impaired cognitive function in older subjects with subjective complaints of memory loss. Int J Cardiol (2013) 0.92
Cardiovascular and metabolic effects of ghrelin. Curr Diabetes Rev (2010) 0.92
Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure. Heart Fail Rev (2013) 0.90
Arterial wall properties and Womersley flow in Fabry disease. BMC Cardiovasc Disord (2002) 0.90
Metabolic and cardiovascular effects of ghrelin. Int J Pept (2010) 0.89
Improved implant and postoperative lead performance in CRT-D patients implanted with a quadripolar left ventricular lead. A 6-month follow-up analysis from a multicenter prospective comparative study. J Interv Card Electrophysiol (2014) 0.88
Sildenafil reduces insulin-resistance in human endothelial cells. PLoS One (2011) 0.85
Plasma ghrelin in anorexia, bulimia, and binge-eating disorder: relations with eating patterns and circulating concentrations of cortisol and thyroid hormones. Neuroendocrinology (2005) 0.85
Peripheral CD45RO, PD-1, and TLR4 expression in metastatic colorectal cancer patients treated with bevacizumab, fluorouracil, and irinotecan (FOLFIRI-B). Med Oncol (2013) 0.84
Leptin stimulates both endothelin-1 and nitric oxide activity in lean subjects but not in patients with obesity-related metabolic syndrome. J Clin Endocrinol Metab (2013) 0.84
Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes. Atherosclerosis (2009) 0.84
Soluble guanylate cyclase: a potential therapeutic target for heart failure. Heart Fail Rev (2013) 0.83
Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy. Atherosclerosis (2012) 0.82
Tumor necrosis factor-alpha antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome. Diabetes Care (2008) 0.81
Effects of peroxisome proliferator-activated receptor-gamma activation with pioglitazone on plasma adipokines in nondiabetic patients with either hypercholesterolemia or hypertension. Am J Cardiol (2008) 0.80
Erythrocyte glutathione transferase activity: a possible early biomarker for blood toxicity in uremic diabetic patients. Acta Diabetol (2013) 0.79
Rho-kinase inhibition improves vasodilator responsiveness during hyperinsulinemia in the metabolic syndrome. Am J Physiol Endocrinol Metab (2012) 0.79
Coronary artery calcifications predict long term cardiovascular events in non diabetic Caucasian hemodialysis patients. Aging (Albany NY) (2015) 0.78
Impact of Malignancies in the Early and Late Time Course of Takotsubo Cardiomyopathy. Circ J (2016) 0.78
Selective cardiac neuroadrenergic abnormalities in hypertensive patients with left ventricular hypertrophy. Arch Med Res (2007) 0.78
Concomitant impairment in endothelial function and neural cardiovascular regulation in offspring of type 2 diabetic subjects. Hypertension (2006) 0.78
Serum glucocorticoid inducible kinase (SGK)-1 protects endothelial cells against oxidative stress and apoptosis induced by hyperglycaemia. Acta Diabetol (2014) 0.78
Occurrence of hypotension in older participants. Which 24-hour ABPM parameter better correlate with? J Gerontol A Biol Sci Med Sci (2012) 0.78
Association between altered circadian blood pressure profile and cardiac end-organ damage in patients with renovascular hypertension. Cardiology (2003) 0.78
Reduction of left ventricular hypertrophy detected by cardiac magnetic resonance in a patient after renal denervation. J Cardiovasc Med (Hagerstown) (2015) 0.77
Helicobacter pylori infection associates with a mucosal downregulation of ghrelin, negative regulator of Th1-cell responses. Helicobacter (2013) 0.76
Asymptomatic QTc prolongation during coadministration of aripiprazole and haloperidol. J Clin Psychiatry (2008) 0.76
Differences between diabetic and non-diabetic hypertensive patients with first acute non-ST elevation myocardial infarction and predictors of in-hospital complications. J Cardiovasc Med (Hagerstown) (2008) 0.76
Flavanol-rich cocoa a promising new dietary intervention to reduce cardiovascular risk in type 2 diabetes? J Am Coll Cardiol (2008) 0.75
Preoperative embolization reduces the risk of cathecolamines release at the time of surgical excision of large pelvic extra-adrenal sympathetic paraganglioma. Case Rep Endocrinol (2012) 0.75
Clinical and electrical performance of currently available MRI-safe pacing systems. Do all devices perform in the same way? Int J Cardiol (2012) 0.75
Plasma levels of cell adhesion molecules during hyperinsulinemia and modulation of vasoactive mediators. Vasc Med (2004) 0.75
Endothelial and perivascular adipose tissue abnormalities in obesity-related vascular dysfunction: novel targets for treatment. J Cardiovasc Pharmacol (2017) 0.75
Insulin resistance and increased intimal medial thickness in glucose tolerant offspring of type 2 diabetic subjects carrying the D298D genotype of endothelial nitric oxide synthase. Arterioscler Thromb Vasc Biol (2006) 0.75
Early detection of high voltage lead failure with an unusual and unexpected device alert. Heart (2013) 0.75
Insulin glargine in enteric tube feeding. Diabetes Res Clin Pract (2007) 0.75
Membership spotlight. Vasc Med (2017) 0.75